Business
Barinthus Biotherapeutics Plc. ADR (BRNS) Is Touching $1.53: At This Price, The Risk Is Justified.
Barinthus Biotherapeutics Plc. ADR (NASDAQ:BRNS) concluded the trading at $1.53 on Thursday, June 04 with a rise of 7.75% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.42 and 5Y monthly